Atrial Natriuretic Peptide rat
SIGMA/A8208 - ≥97% (HPLC)
Synonym: α-Atriopeptin, rat; α-rANP; ANF (123-150), rat; ANF 1-28; rANP
CAS Number: 88898-17-3
Empirical Formula (Hill Notation): C128H205N45O39S2
Molecular Weight: 3062.41
MDL Number: MFCD00076228
Linear Formula: C128H205N45O39S2
Product Type: Chemical
| assay | ≥97% (HPLC) |
| composition | Peptide content, ≥70% |
| form | powder |
| InChI | 1S/C128H205N45O39S2/c1-10 |
| InChI key | QGFSVPWZEPKNDV-BRTFOEFASA |
| Quality Level | 200 ![]() |
| SMILES string | CC[C@H](C)[C@@H]1NC(=O)[C |
| storage temp. | −20°C |
| UniProt accession no. | P01161 ![]() |
| Amino Acid Sequence: | Ser-Leu-Arg-Arg-Ser-Ser-C |
| Application: | Atrial Natriuretic Peptide rat has been used: • In the absorption test to confirm the specificity of the anti-NP antibodies. • To study the effects of atrial natriuretic peptide (ANP) on renal water and sodium regulation in rats. • To study the integrated biological effects of ANP on myocardial infarction using mice models. |
| Biochem/physiol Actions: | ANP production is regulated by factors associated with developmental, hormonal and hemodynamic processes. Its secretion is stimulated by atrial wall stretch, and ischemia. |
| Biochem/physiol Actions: | Atrial natriuretic peptide (ANP) is synthesized in myoendocrine cells of the heart from which it is released into the circulation. It exerts natriuretic, diuretic, and vasodilatory effects through stimulation of guanylate cyclase-linked NPR-A receptors. It plays an important role in blood volume and blood pressure homeostasis. |
| Biochem/physiol Actions: | Exerts natriuretic, diuretic, and vasodilatory effects through stimulation of guanylate cyclase-linked NPR-A receptors. |
| Other Notes: | Lyophilized from 0.1% TFA in H2O |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥97% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 51111800 |

